Innovation

A new class of effective and affordable medicine for pets

Saiba Animal Health has developed a novel and innovative vaccine platform that is based on non-infectious virus-like particles in order to treat chronic inflammatory diseases, cancer and allergy in pets.

The VLPs represent a highly ordered molecular assembly system eliciting strong antibody responses. Saiba Animal Health can easily adapt the innovative VLP vaccine platform to target any disease-associated molecule taking advantage of the latest and most effective innovations in human medicines, specifically monoclonal antibody therapy, and turn them into a new, efficacious and affordable class of veterinary vaccine-based medicine.

Our vaccines instruct the pet’s immune system to make target-specific antibodies, which can inhibit any disease-promoting or disease-associated molecules. Saiba Animal Health’s platform technology can also be accommodated to produce conventional vaccines suitable for preventing infectious diseases in companion animals and livestock.